The Ministry of Health has updated the Covid-19 treatment guide. The active ingredient of Hydroxychloroquine, which has been used in the treatment of the disease and has been discussed for a while due to its side effects, was removed from the guide.
Accordingly, corona virus patients who are treated both in the hospital and at home will not be given medication with the active ingredient Hydroxychloroquine.
Head of Pediatric Infectious Diseases Department Prof. Dr. Mehmet Ceyhan made a statement on his Twitter account about the Favipiravir drug used in the treatment, which was wondered by patients who had coronavirus.
That drug will no longer be used in coronavirus treatment
Prof. Dr. Ceyhan made a statement with the title “Is Favipiravir reliable and effective in the treatment of Covid-19?” “Its claims of effectiveness are in press releases and in Chinese publications rather than in medical journals.
Prof. Dr. Ceyhan, Favipiravir, on the difference from Hydroxychloroquine, “Hydroxychloroquine does not cause side effects, which are of great importance in terms of safety, so it is widely used. We have never used Hydroxychloroquine for children from the very beginning, and we do not use Favipiraviri except in rare cases. Antibodies such as Banlanivimab, which may be more effective in treatment, are very expensive and can only be used in the early period for those who are at risk of severe disease. Patients who have used favipiravir do not need to be worried, there is no evidence that side effects, which are important in a long time, have developed. As a result, the most effective treatment is still supportive therapy rather than drug therapy; liquid, oxygen, observation when necessary ”.